HeartWare International Inc  

(Public, NASDAQ:HTWR)   Watch this stock  
Find more results for htwr
57.98
0.00 (0.00%)
Pre-market: 57.98 0.00 (0.00%)
Aug 23, 8:37AM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 25.01 - 87.38
Open     -
Vol / Avg. 762.00/217,488.00
Mkt cap 1.02B
P/E     -
Div/yield     -
EPS -3.40
Shares 17.56M
Beta 0.30
Inst. own 91%
Oct 27, 2016
Q3 2016 HeartWare International Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin -15.84% -26.29%
Operating margin -9.26% -13.45%
EBITD margin - -11.92%
Return on average assets -10.14% -16.59%
Return on average equity -25.32% -36.66%
Employees 625 -
CDP Score - -

Address

500 Old Connecticut Path
FRAMINGHAM, MA 1701
United States - Map
+1-508-7390873 (Phone)
+1-508-7390948 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery. The HVAD System features the centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. It develops MVAD System, a miniaturized device. The CircuLite Surgical System is designed to be implanted through a right, mini-thoracotomy procedure and does not require a sternotomy or cardiopulmonary bypass.